Buscar
Mostrando ítems 1-10 de 313
Update of the statements on biology and clinical impact of occult hepatitis B virus infection
In October 2018 a large number of international experts with complementary expertise came together in Taormina to participate in a workshop on occult hepatitis B virus infection (OBI). The objectives of the workshop were ...
HBV vaccination of HCV-infected patients with occult HBV infection and anti-HBc-positive blood donors
(Associação Brasileira de Divulgação Científica, 2006)
Características subgenotípicas, filogenéticas e correlação entre os níveis séricos do antígeno de superfície do vírus da hepatite B e o HBV DNA (viremia). Recife, Brasil
(Universidade Federal de Pernambuco, 2014)
Pesquisa do HBV-DNA em doadores de sangue com diferentes perfis sorológicos para hepatite B
(Universidade Federal de Pernambuco, 2014)
The influence of occult infection with hepatitis B virus on liver histology and response to interferon treatment in chronic hepatitis C patients
(Brazilian Society of Infectious Diseases, 2004)
Efficacy and safety of entecavir for chronic HBV in HIV/HBV coinfected patients receiving lamivudine as part of antiretroviral therapy
(LIPPINCOTT WILLIAMS & WILKINS, 2008)
Background: Prolonged use of lamivudine in patients coinfected with HIV and hepatitis B virus (HBV) leads to an increasing risk of lamivudine resistance in both diseases. We investigated the addition of entecavir, a potent ...
The biological meaning of anti-HBC positive result in blood donors: relation to HBV-DNA and to other serological markers
(Instituto de Medicina Tropical, 2003-06)
In order to assess the potential risk of anti-HBc-positive blood donors for post-transfusional hepatitis and to investigate whether other HBV serological markers are capable of identifying the presence of the virus, 1000 ...
A comparison of molecular methods for hepatitis B virus (HBV) DNA detection from oral fluid samples
(Microbiology Society, 2017)
A comparison of hepatitis B virus infection in HIV-infected and HIV-uninfected participants enrolled in a multinational clinical trial: HPTN 052
(Lippincott, Williams & Wilkins, 2019)